Neurology

AI Could Add $461 Billion to Global Healthcare–And These New Platforms Are Leading the ChargeAI Could Add $461 Billion to Global Healthcare–And These New Platforms Are Leading the Charge

AI Could Add $461 Billion to Global Healthcare–And These New Platforms Are Leading the Charge

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 23, 2025 /PRNewswire/ -- Equity Insider…

1 month ago
Neurostimulation Devices Market to Reach USD 17.2 Billion by 2031 – Driven by Demand for Pain and Parkinson’s Therapies | Valuates ReportsNeurostimulation Devices Market to Reach USD 17.2 Billion by 2031 – Driven by Demand for Pain and Parkinson’s Therapies | Valuates Reports

Neurostimulation Devices Market to Reach USD 17.2 Billion by 2031 – Driven by Demand for Pain and Parkinson’s Therapies | Valuates Reports

BANGALORE, India, May 22, 2025 /PRNewswire/ -- Neurostimulation Devices Market is Segmented by Type (Spinal Cord Stimulation (SCS), Gastric Electric…

1 month ago
Artificial Intelligence in Diagnostics Market Size worth US$ 5.44 billion by 2030 – Exclusive Report by The Research InsightsArtificial Intelligence in Diagnostics Market Size worth US$ 5.44 billion by 2030 – Exclusive Report by The Research Insights

Artificial Intelligence in Diagnostics Market Size worth US$ 5.44 billion by 2030 – Exclusive Report by The Research Insights

CHICAGO, May 21, 2025 /PRNewswire/ -- The global Artificial Intelligence in Diagnostics Market Size is projected to be valued at USD 1.97…

1 month ago
Neurophet Participates ASNR 2025: Showcasing Clinical Utility of ‘Neurophet AQUA AD’Neurophet Participates ASNR 2025: Showcasing Clinical Utility of ‘Neurophet AQUA AD’

Neurophet Participates ASNR 2025: Showcasing Clinical Utility of ‘Neurophet AQUA AD’

Co-CEO Jake Junkil Been joins Industry Collaboration Session to present Neurophet's brain imaging analysis technologies, including Neurophet AQUA ADCompany accelerates…

1 month ago
Neurogen Biomarking Announces Partnership with AransciaNeurogen Biomarking Announces Partnership with Aranscia

Neurogen Biomarking Announces Partnership with Aranscia

Aranscia Diagnostic Laboratory and Technology Solutions Support Neurogen's Innovative Platform for the Early Detection of Mild Cognitive Impairment (MCI) and…

1 month ago
Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy StudyRoute 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study

Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study

Data from 250-patient, 31-center, randomized controlled trial presented at European Stroke Organisation Conference Three highest enrolling sites reported 96% delivery…

1 month ago
Rapport Therapeutics to Host 2025 Investor and Analyst DayRapport Therapeutics to Host 2025 Investor and Analyst Day

Rapport Therapeutics to Host 2025 Investor and Analyst Day

BOSTON and SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company dedicated…

1 month ago
ESOC 2025: Combined oral contraceptives triple risk of cryptogenic stroke in young women, new study showsESOC 2025: Combined oral contraceptives triple risk of cryptogenic stroke in young women, new study shows

ESOC 2025: Combined oral contraceptives triple risk of cryptogenic stroke in young women, new study shows

HELSINKI, May 20, 2025 /PRNewswire/ -- New research presented today at the European Stroke Organisation Conference (ESOC) 2025 revealed that…

1 month ago